Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 i... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
0
Authors
Eriseld Krasniqi
67 more
Eriseld Krasniqi
•
Lorena Filomeno
65 more
•
Patrizia Vici
Published
December 7, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
HER2-positive breast cancer (HER2
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancers
Topics
Medicine
Cancer Oncology
Internal Medicine
Cancer Research
Trastuzumab
Show all topics
DOI
10.3390/cancers16234104
